SEC Form 4 · accession 0001178031-16-000002
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ralph Snyderman
Director
Period of report
Dec 9, 2016
Accepted (ET)
Dec 13, 2016 · 12:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.90 | Dec 9, 2016 | A | 30,000 | A | — | Dec 8, 2026 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1This option was granted on December 9, 2016 and vests in equal amounts quarterly over the next three years.